查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701285

药物发现资讯学市场规模、份额、趋势分析报告：按服务、应用、最终用途、地区、细分市场预测，2025-2030 年

Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Service (Molecular Modelling), By Application (Discovery Informatics), By End-use (Academic & Research Institutes), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

药物发现资讯学市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球药物发现资讯学市场预计到2030年将达到70.3亿美元，2025年至2030年的复合年增长率为11.6%。

由于快速的药物设计和合成、有效追踪疾病进展和资料完整性管理等多种优势，近年来，研究人员使用药物发现软体获取市场情报的情况显着增加，从而推动了该行业的成长。

对新型分子的需求不断增长，推动了资讯学解决方案的采用，旨在透过目标大分子相互作用来识别合理的药物分子，从而加快整个药物发现过程。在市场上运营的公司正在获得资金来扩大其药物发现平台，进一步推动市场成长。例如，2020年9月，Ardigen与国家研究发展中心签署协议，获得新技术开发的资金。

该技术旨在彻底改变基于 T 细胞受体的免疫肿瘤治疗方法的发展。先前，ArdImmune Vax 开发了一个新抗原预测平台，部署了即用型人工智慧 (AI) 和生物资讯解决方案，以确定最佳新抗原作为过继性细胞疗法和癌症疫苗的标靶。此外，化学资讯学解决方案在过去一年中获得了显着的发展，特别是在满足与最近的 COVID-19 大流行相关的需求方面。

例如，2021年1月进行的一项研究展示了透过对SARS-CoV主蛋白酶（Mpro）抑制剂的历史活性资料进行资料分析，应用化学数位解决方案来加速SARS-CoV-2 Mpro抑製剂的发现。此外，QSAR 模型有助于分子资料探勘，从而快速发现 COVID-19 药物。因此，加快 COVID-19 药物开发的需求预计将在未来几年推动产业扩张。

药物发现资讯学市场报告重点

  • 序列分析平台将主导市场，到 2024 年将占据 36.4% 的最大收益占有率。生物资讯解决方案被广泛用于开发核酸、蛋白质和其他生物分子序列的一级和二级资料库。
  • 2024 年，药物发现资讯学领域将占最大收入份额，约 60.2%，主要专注于精准医疗开发。精准医疗的核心是提供根据个人基因和分子特征量身定制的个人化医疗。
  • 製药和生物技术公司将主导市场，到 2024 年将获得 48.4% 的最大收益占有率。这一增长是由研发支出的增加所推动的，尤其是在精准医疗领域。
  • 由于主要市场参与者的存在和完善的研发基础设施，北美在 2024 年引领全球市场。

目录

第一章调查方法与范围

第二章执行摘要

第三章药物发现资讯学市场变数、趋势和范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章药物发现资讯学市场：按服务分類的业务分析

  • 2024 年及 2030 年各服务市场占有率
  • 服务细分细分仪表板
  • 市场规模、预测与趋势分析（按服务，2018-2030 年）
  • 序列分析平台
  • 分子建模
  • 对接
  • 临床试验资料管理
  • 其他的

第五章药物发现资讯学市场：按应用进行的业务分析

  • 2024 年及 2030 年各应用领域的市场占有率
  • 应用程式细分仪表板
  • 市场规模、预测与趋势分析（按应用，2018-2030 年）
  • 药物发现资讯学
  • 生物内容管理

第六章药物发现资讯学市场：最终使用者的业务分析

  • 2024 年和 2030 年按最终用途分類的市场占有率
  • 最终用途细分仪表板
  • 按最终用途分類的市场规模、预测和趋势分析（2018-2030 年）
  • 製药和生物技术公司
  • CRO 和 CMO
  • 学术研究所

第七章药物发现资讯学市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 市场规模、预测趋势分析，2018 年至 2030 年：
  • 北美洲
    • 2018-2030年各国情况
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年各国情况
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年各国情况
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2018-2030年各国情况
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年各国情况
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/列表
    • Certara
    • Boehringer Ingelheim International GmbH
    • Infosys Ltd.
    • Charles River Laboratories
    • Collaborative Drug Discovery, Inc.
    • Eurofins DiscoverX Products
    • Jubliant Biosys
    • Selvita
    • Novo Informatics Pvt. Ltd.
    • ChemAxon Ltd.
    • Albany Molecular Research Inc.
    • Oracle
    • Accenture
    • Agilent Technologies, Inc.
    • Illumina, Inc.
Product Code: 978-1-68038-749-0

Drug Discovery Informatics Market Growth & Trends:

The global drug discovery informatics market size is expected to reach USD 7.03 billion by 2030, registering a CAGR of 11.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth.

The growing demand for novel molecules is driving the adoption of informatics solutions targeted towards speeding up the entire drug discovery process by identifying rational drug molecules via the target macromolecule interaction. Companies operating in the market are receiving funding for expanding their drug discovery platforms, further supplementing the market growth. For instance, in September 2020, Ardigen signed an agreement with the National Centre for Research and Development to access its funding for developing novel technology.

This technology was aimed at revolutionizing the development of T-cell receptors-based therapies for immuno-oncology. Ardigen has previously developed a neoantigen prediction platform namely, ArdImmune Vax, which deploys ready-to-use Artificial Intelligence (AI) and bioinformatics solutions for the identification of optimal sets of neoantigens as targets for adoptive cell therapies and cancer vaccines. In addition, chemical informatics solutions have gained considerable traction in the past year, particularly in addressing the needs associated with the recent Covid-19 pandemic.

For instance, a research study performed in January 2021 showcased the application of chemical digital solutions in accelerating the search of SARS-CoV-2 Mpro inhibitors by data analysis of previous activity data of SARS-CoV main protease (Mpro) inhibitors. In addition, the QSAR models helped in the data mining of molecules for rapid Covid-19 drug discovery. Hence, the need to facilitate drug development for Covid-19 is expected to propel the industry expansion over the coming years.

Drug Discovery Informatics Market Report Highlights:

  • The sequence analysis platforms dominated the market and accounted for the largest revenue share of 36.4% in 2024. Bioinformatics solutions are widely employed for the development of primary and secondary databases of nucleic acids, proteins, and other biomolecule sequences.
  • The discovery informatics segment accounted for the largest revenue share of around 60.2% in 2024, with a major focus on developing precision medicines. Precision medicine revolves around providing personalized medical care tailored to an individual's genetic and molecular profile.
  • Pharmaceutical and biotechnology companies held the dominant position in the market, with the largest revenue share of 48.4% in 2024. This growth is attributed to increased R&D spending, particularly in precision medicine.
  • North America led the global market in 2024 due to the presence of key market players and established R&D infrastructure in the country

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Drug Discovery Informatics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Drug Discovery Informatics Market: Service Business Analysis

  • 4.1. Service Market Share, 2024 & 2030
  • 4.2. Service Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 4.4. Sequence Analysis Platforms
    • 4.4.1. Sequence Analysis Platforms Market, 2018 - 2030 (USD Million)
  • 4.5. Molecular Modelling
    • 4.5.1. Molecular Modelling Market, 2018 - 2030 (USD Million)
  • 4.6. Docking
    • 4.6.1. Docking Market, 2018 - 2030 (USD Million)
  • 4.7. Clinical Trial Data Management
    • 4.7.1. Clinical Trial Data Management Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Drug Discovery Informatics Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Discovery Informatics
    • 5.4.1. Discovery Informatics Market, 2018 - 2030 (USD Million)
  • 5.5. Biocontent Management
    • 5.5.1. Biocontent Management Market, 2018 - 2030 (USD Million)

Chapter 6. Drug Discovery Informatics Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.5. CROs & CMOs
    • 6.5.1. CROs & CMOs Market, 2018 - 2030 (USD Million)
  • 6.6. Academic & Research Institutes
    • 6.6.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)

Chapter 7. Drug Discovery Informatics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. Australia Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Thailand Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. South Korea Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Certara
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Boehringer Ingelheim International GmbH
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Infosys Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Charles River Laboratories
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Collaborative Drug Discovery, Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Eurofins DiscoverX Products
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Jubliant Biosys
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Selvita
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Novo Informatics Pvt. Ltd.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. ChemAxon Ltd.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Albany Molecular Research Inc.
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Oracle
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. Accenture
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives
    • 8.5.14. Agilent Technologies, Inc.
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial Performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic Initiatives
    • 8.5.15. Illumina, Inc.
      • 8.5.15.1. Overview
      • 8.5.15.2. Financial Performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic Initiatives

List of Tables

  • Table 1. List Of Secondary Sources
  • Table 2. List Of Abbreviations
  • Table 3. Global Drug Discovery Informatics Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 5. Global Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 6. Global Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7. North America Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
  • Table 8. North America Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 9. North America Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 10. North America Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11. U.S. Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 12. U.S. Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 13. U.S. Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 14. Canada Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 15. Canada Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 16. Canada Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 17. Mexico Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 18. Mexico Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 19. Mexico Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. Europe Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
  • Table 21. Europe Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 22. Europe Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 23. Europe Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24. UK Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 25. UK Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 26. UK Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 27. Germany Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 28. Germany Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 29. Germany Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30. France Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 31. France Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 32. France Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 33. Italy Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 34. Italy Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 35. Italy Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36. Spain Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 37. Spain Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 38. Spain Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39. Denmark Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 40. Denmark Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 41. Denmark Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 42. Sweden Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 43. Sweden Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 44. Sweden Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45. Norway Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 46. Norway Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 47. Norway Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52. Japan Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 53. Japan Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 54. Japan Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 55. China Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 56. China Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 57. China Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 58. India Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 59. India Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 60. India Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Australia Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 62. Australia Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 63. Australia Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 64. Thailand Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 65. Thailand Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 66. Thailand Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 67. South Korea Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 68. South Korea Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 69. South Korea Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 70. Latin America Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
  • Table 71. Latin America Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 72. Latin America Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 73. Latin America Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 74. Brazil Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 75. Brazil Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 76. Brazil Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 77. Argentina Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 78. Argentina Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 79. Argentina Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 84. South Africa Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 85. South Africa Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 86. South Africa Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 90. UAE Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 91. UAE Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 92. UAE Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 93. Kuwait Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 94. Kuwait Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 95. Kuwait Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Drug Discovery Informatics Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Service and Application Outlook (USD Million)
  • Fig. 10 End Use Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 Drug Discovery Informatics Market Dynamics
  • Fig. 13 Drug Discovery Informatics Market: Porter's Five Forces Analysis
  • Fig. 14 Drug Discovery Informatics Market: PESTLE Analysis
  • Fig. 15 Drug Discovery Informatics Market: Service Segment Dashboard
  • Fig. 16 Drug Discovery Informatics Market: Service Market Share Analysis, 2024 & 2030
  • Fig. 17 Sequence Analysis Platforms Market, 2018 - 2030 (USD Million)
  • Fig. 18 Molecular Modelling Market, 2018 - 2030 (USD Million)
  • Fig. 19 Docking Market, 2018 - 2030 (USD Million)
  • Fig. 20 Clinical Trial Data Management Market, 2018 - 2030 (USD Million)
  • Fig. 21 Others Market, 2018 - 2030 (USD Million)
  • Fig. 22 Drug Discovery Informatics Market: Application Segment Dashboard
  • Fig. 23 Drug Discovery Informatics Market: Application Market Share Analysis, 2024 & 2030
  • Fig. 24 Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 25 Biocontent Management Market, 2018 - 2030 (USD Million)
  • Fig. 26 Drug Discovery Informatics Market: End Use Segment Dashboard
  • Fig. 27 Drug Discovery Informatics Market: End Use Market Share Analysis, 2024 & 2030
  • Fig. 28 Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • Fig. 29 CROs & CMOs Market, 2018 - 2030 (USD Million)
  • Fig. 30 Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • Fig. 31 Drug Discovery Informatics Market Revenue, By Region
  • Fig. 32 Regional Marketplace: Key Takeaways
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 North America Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Country Dynamics
  • Fig. 36 U.S. Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada Country Dynamics
  • Fig. 38 Canada Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico Country Dynamics
  • Fig. 40 Mexico Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Country Dynamics
  • Fig. 43 UK Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Country Dynamics
  • Fig. 45 Germany Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Country Dynamics
  • Fig. 47 France Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy Country Dynamics
  • Fig. 49 Italy Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain Country Dynamics
  • Fig. 51 Spain Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway Country Dynamics
  • Fig. 53 Norway Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden Country Dynamics
  • Fig. 55 Sweden Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark Country Dynamics
  • Fig. 57 Denmark Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan Country Dynamics
  • Fig. 60 Japan Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 61 China Country Dynamics
  • Fig. 62 China Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 63 India Country Dynamics
  • Fig. 64 India Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia Country Dynamics
  • Fig. 66 Australia Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand Country Dynamics
  • Fig. 68 Thailand Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 69 South Korea Country Dynamics
  • Fig. 70 South Korea Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil Country Dynamics
  • Fig. 73 Brazil Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina Country Dynamics
  • Fig. 75 Argentina Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 76 MEA Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa Country Dynamics
  • Fig. 78 South Africa Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia Country Dynamics
  • Fig. 80 Saudi Arabia Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 81 UAE Country Dynamics
  • Fig. 82 UAE Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 83 Kuwait Country Dynamics
  • Fig. 84 Kuwait Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 85 Company Categorization
  • Fig. 86 Company Market Position Analysis
  • Fig. 87 Strategic Framework